nifedipine has been researched along with cerivastatin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Brendel, E; Horstmann, R; Kuhlmann, J; Mück, W; Ochmann, K; Rohde, G; Sachse, R | 1 |
| Cesari, M; Pessina, AC | 1 |
| Adachi, T; Colucci, WS; Ido, Y; Ito, M; Pimentel, DR | 1 |
| Eto, Y; Fukumoto, Y; Kandabashi, T; Kunihiro, I; Matsumoto, Y; Morishige, K; Shimokawa, H; Takeshita, A | 1 |
1 review(s) available for nifedipine and cerivastatin
| Article | Year |
|---|---|
Combined antihypertensive and lipid-lowering treatment.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Arteriosclerosis; Cardiovascular Diseases; Comorbidity; Drug Therapy, Combination; Endothelium, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Nifedipine; Pyridines; Simvastatin | 2004 |
2 trial(s) available for nifedipine and cerivastatin
| Article | Year |
|---|---|
Lack of drug-drug interaction between cerivastatin and nifedipine.
Topics: Administration, Oral; Adult; Area Under Curve; Biological Availability; Calcium Channel Blockers; Cross-Over Studies; Drug Interactions; Half-Life; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Nifedipine; Pyridines | 1998 |
Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function).
Topics: Acetylcholine; Adult; Calcium Channel Blockers; Cholesterol; Coronary Artery Disease; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardium; Nifedipine; Pyridines; Vasoconstriction | 2003 |
9 other study(ies) available for nifedipine and cerivastatin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Statins inhibit beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes via a Rac1-dependent mechanism.
Topics: Animals; Apoptosis; Calcium; Calcium Channel Blockers; Cells, Cultured; Depression, Chemical; Drug Evaluation, Preclinical; Heart Ventricles; Hydroxymethylglutaryl-CoA Reductase Inhibitors; JNK Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Nifedipine; Norepinephrine; Pyridines; rac1 GTP-Binding Protein; Rats; Reactive Oxygen Species; Receptors, Adrenergic, beta; Recombinant Fusion Proteins; Signal Transduction | 2004 |
Combination therapy with cerivastatin and nifedipine improves endothelial dysfunction after balloon injury in porcine coronary arteries.
Topics: Administration, Oral; Animals; Blood Chemical Analysis; Blotting, Western; Bradykinin; Calcimycin; Catheterization; Coronary Angiography; Coronary Vessels; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelium, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Male; Nifedipine; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Nitroprusside; Pyridines; Serotonin; Swine; Vasodilation; Vasodilator Agents | 2005 |